ロード中...
Improving the pharmacokinetics, biodistribution and plasma stability of monobodies
Cancer is a leading cause of death worldwide. Several targeted anticancer drugs entered clinical practice and improved survival of cancer patients with selected tumor types, but therapy resistance and metastatic disease remains a challenge. A major class of targeted anticancer drugs are therapeutic...
保存先:
| 出版年: | Front Pharmacol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2024
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7615827/ https://ncbi.nlm.nih.gov/pubmed/38617793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2024.1393112 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|